ProPhase Labs, Inc.
PRPH
$0.11
-$0.02-16.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.06M | 5.59M | 5.85M | 6.77M | -625.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.06M | 5.59M | 5.85M | 6.77M | -625.00K |
| Cost of Revenue | 4.07M | 4.26M | 5.41M | 6.92M | 3.11M |
| Gross Profit | 987.00K | 1.33M | 436.00K | -150.00K | -3.74M |
| SG&A Expenses | 30.43M | 32.37M | 34.68M | 37.89M | 27.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.67M | 36.92M | 40.51M | 45.40M | 31.67M |
| Operating Income | -29.61M | -31.33M | -34.66M | -38.63M | -32.30M |
| Income Before Tax | -34.38M | -34.86M | -38.92M | -42.33M | -34.58M |
| Income Tax Expenses | 15.18M | 12.83M | 9.76M | 7.20M | -10.28M |
| Earnings from Continuing Operations | -49.56 | -47.69 | -48.68 | -49.53 | -24.30 |
| Earnings from Discontinued Operations | 7.86M | 6.24M | 5.55M | -3.84M | -3.05M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.70M | -41.45M | -43.13M | -53.36M | -27.76M |
| EBIT | -29.61M | -31.33M | -34.66M | -38.63M | -32.30M |
| EBITDA | -24.22M | -25.45M | -28.60M | -32.44M | -26.02M |
| EPS Basic | -1.75 | -1.93 | -2.15 | -2.61 | -1.52 |
| Normalized Basic EPS | -0.73 | -0.86 | -1.08 | -1.28 | -1.18 |
| EPS Diluted | -1.75 | -1.93 | -2.15 | -2.61 | -1.52 |
| Normalized Diluted EPS | -0.73 | -0.86 | -1.08 | -1.28 | -1.18 |
| Average Basic Shares Outstanding | 138.78M | 116.32M | 93.66M | 76.48M | 73.22M |
| Average Diluted Shares Outstanding | 138.78M | 116.32M | 93.66M | 76.48M | 73.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |